Cancer is ranked as the second leading cause of death globally. Traditional cancer
therapies including chemotherapy are flawed, with off-target and on-target toxicities on the …

Recent progress in protein-based nanomedicine, inspired by the success of Abraxane®
albumin-paclitaxel nanoparticles, have resulted in novel therapeutics used for treatment of …

Abstract Rationale: Iron-saturated Lf (Holo-Lactoferrin, Holo-Lf) exhibits a superior
anticancer property than low iron-saturated Lf (Apo-Lf). Ferroptosis is an iron-dependent cell …

Chemotherapy with a single chemotherapeutic agent or a combined chemotherapeutic
regimen is the clinically standardized treatment for almost all human cancers. Upregulated …

Despite the clinical approval of few nanomedicines for cancer therapy, some drawbacks still
impede their improved efficiency including low drug loading, off-target toxicity and …

Nanomaterials with cancer‐imaging and therapeutic properties have emerged as the
principal focus of nanotheranostics. The past decade has experienced a significant increase …

Nanotechnology is the science of nanoscale, which is the scale of nanometers or one
billionth of a meter. Nanotechnology encompasses a broad range of technologies, materials …

Nanoparticle (NP)-mediated drug delivery (NMDD) for active targeting of diseases is a
primary goal of nanomedicine. NPs have much to offer in overcoming the limitations of …

Cancer is one of the major leading causes of mortality in the world. The implication of
nanotherapeutics in cancer has garnered splendid attention owing to their capability to …

The global burden of cancer increases with the passing year and is becoming the primary
cause of death globally. Chemotherapy plays an important role but produces side effects …